[Synthesized from academic records + research fields]
Research interests: Renal cell carcinoma treatment, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Renal and related cancers, Cancer Genomics and Diagnostics
Affiliation: Fred Hutchinson Cancer Research Center
Recent publications: "A phase I/II study of the safety and efficacy of telaglenastat (CB-839) in combination with nivolumab in patients with metastatic melanoma, renal cell carcinoma, and…"; "Telemedicine for Multidisciplinary Urologic Cancer Care: A Prospective Single Institution Study"; "Supplementary Data from First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of…"
